MB
Publicaties op Oncologisch.com
Final analysis of nivolumab plus cabozantinib for gevorderd renal cell carcinoma from the gerandomiseerde phase III C...
Gerandomiseerde, double-blind, phase III LEAP-003 study of eerstelijns lenvatinib plus pembrolizumab versus placebo p...
Pembrolizumab plus enzalutamide versus placebo plus enzalutamide for chemotherapy-naive metastatic castration-resista...
Subcutaan versus intraveneus nivolumab bij niercelcarcinoom
Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: extended 8-year...
Subcutaan atezolizumab: IMscin001 fase III farmacokinetiek